(+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2h)-yl)methyl]imidazolidine-2,4-dione and drug containing same

• 收藏
• 分享

专利权人:

KAKEN PHARMACEUTICAL CO. LTD.

发明人:

Kamei Noriyuki,Kamimura Daigo,Sumikawa Yoshitake,Tokuoka Shota

申请号：

NZ71470014

公开号：

NZ714700A

申请日:

2014.06.06

申请国别(地区):

NZ

年份:

2020

代理人:

摘要：

Provided is (+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2H)-yl)methyl]imidazolidine-2,4-dione or a salt thereof, a selective TACE inhibitor and its use in the treatment of conditions caused by the excessive production and secretion of TNF-α. Also provided is a drug containing as the active ingredient (+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2H)-yl)methyl]imidazolidine-2,4-dione or a salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/